Advertisement

Topics

Partners for Development investments in Life Sciences, P.U.L.S. AB Company Profile

06:38 EST 10th December 2018 | BioPortfolio

Partners for Development investments in Life Sciences, P.U.L.S. AB (PULS) was founded in 2002. PULS acts as an incubator and investor for early projects within life science, mostly drug development, and has started nine project companies.

PULS consist of an operational management team and more than 30 partners with long experience in life sciences and competence through the whole value chain, from R&D to commercialisation.

PULS business model is to engage early with innovators to attain an optimal IP platform and high quality development throughout the project. By providing capital, knowledge and cost effective management, the common objective is to maximise, clarify and realise the value of project ideas through a successful exit.

PULS vision is to make significant contributions in the life sciences industry through a combined investment and incubator undertaking with a focus on pharmaceuticals and medical technology, and on long-term profitability.

PULS mission is to maximize the value of life science ideas and initiatives by forming project companies, in shared ownership with innovators – a partnership to which PULS brings world class scientific and industrial competence and secures long-term financing.

Location

Kullagatan 8
Helsingborg
252 20
Sweden

Contact

Phone: +46 (0)42 38 74 18
Fax: +46 (0)42 38 74 01
Email: pontus.ottosson@pulsinvest.se


News Articles [3987 Associated News Articles listed on BioPortfolio]

2m Seed Funding Raised For Life Sciences

Investment manager Deepbridge Capital has today announced the £2m funding of 12 seed stage life sciences companies.Deepbridge raised funds via the Deepbridge Life Sciences SEIS proposition, laun...

Continuing Professional Development for Industry

As one of the leading research-led Life Science faculties in Europe the Faculty of Life Sciences at The University of Manchester has a wealth of experience and expertise in all aspects of biological a...

UCB to invest £1bn into UK under life sciences sector deal

The government has published the second Life Sciences Sector Deal, detailing both public and private sector investments into the sector, including a £1 billion investment in UK research and developme...

UCB to invest £1 billion into UK R&D

The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector Deal, which details public and private sector invest...

Frazier Healthcare Partners Adds Two Experienced Professionals to Life Sciences Team

Frazier Healthcare Partners announced the addition of two new members to its Life Sciences team: Tracy Saxton, Ph.D. as an Entrepreneur-in-Residence (EIR), and Vanessa Bhark as a ...

Blackstone to acquire leading life sciences investment firm, Clarus

Blackstone today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life scienc...

Blackstone buys Clarus to bulk up in life sciences

Blackstone Group LP said on Thursday it has agreed to acquire life sciences investment firm Clarus, in an effort by the world's largest alternative asset manager to scale up its investments in healthc...

Epic Sciences closes $52mm Series E round

Epic Sciences Inc. raised $52mm through its Series E round led by Blue Ox Healthcare Partners. Deerfield Management and Varian also participated, along with existing investors Altos Capital Partners, ...

PubMed Articles [4766 Associated PubMed Articles listed on BioPortfolio]

Medical Writing Competency Model - Section 2: Knowledge, Skills, Abilities, and Behaviors.

This article provides Section 2 of the 2017 Edition 2 Medical Writing Competency Model that describes the knowledge, skills, abilities, and behaviors that professional medical writers need in order to...

Medical Writing Competency Model - Section 1: Functions, Tasks, and Activities.

This article provides Section 1 of the 2017 Edition 2 Medical Writing Competency Model that describes the core work functions and associated tasks and activities related to professional medical writin...

Translation of evidence to practice to promote early childhood development programs.

The 2018 special issue of Annals of the New York Academy of Sciences on implementation research and practice for early childhood development brings together emerging evidence on implementing effective...

My partner's stories: relationships between personal and vicarious life stories within romantic couples.

In this paper, we examined relationships and differences between personal and vicarious life stories, i.e., the life stories one knows of others. Personal and vicarious life stories of both members of...

Sexual life quality of spinal cord-injured men receiving pharmacological treatment for erectile dysfunction and their partners.

To assess the quality of sexual life reported by spinal cord-injured men treated with oral drugs for erectile dysfunction (ED) and their female partners.

Clinical Trials [4810 Associated Clinical Trials listed on BioPortfolio]

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

RATIONALE: Telephone counseling after radical prostatectomy may help African American prostate cancer survivors and their intimate partners cope with the problems and challenges of surgery...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [4619 Associated Companies listed on BioPortfolio]

Life Sciences Partners

Life Sciences Partners ("LSP") is a leading European venture capital fund, providing private equity capital to early stage life sciences companies. Based in Amsterdam and Munich, LSP’s management ha...

Partners for Development investments in Life Sciences, P.U.L.S. AB

Partners for Development investments in Life Sciences, P.U.L.S. AB (PULS) was founded in 2002. PULS acts as an incubator and investor for early projects within life science, mostly drug development,...

CHARTER LIFE SCIENCES (“CLS”)

CHARTER LIFE SCIENCES (“CLS”) is an early stage life sciences venture capital investor. CLS makes initial portfolio company investments in early stage life sciences companies (see Investment Crite...

BioJerusalem

An initiative of the Jerusalem Development Authority, BioJerusalem was founded to help fuel the economic development of Jerusalem by leveraging the vast life sciences resources av...

SV Life Sciences

SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams.SV Life Sciences provides finance to businesses at all stages of develop...

More Information about "Partners for Development investments in Life Sciences, P.U.L.S. AB" on BioPortfolio

We have published hundreds of Partners for Development investments in Life Sciences, P.U.L.S. AB news stories on BioPortfolio along with dozens of Partners for Development investments in Life Sciences, P.U.L.S. AB Clinical Trials and PubMed Articles about Partners for Development investments in Life Sciences, P.U.L.S. AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Partners for Development investments in Life Sciences, P.U.L.S. AB Companies in our database. You can also find out about relevant Partners for Development investments in Life Sciences, P.U.L.S. AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record